Pharmaceutical companies are investing in space-based labs to explore new drug development techniques, leveraging microgravity to enhance chemical processes and crystallization, with companies like Varda Space Industries, Axiom, and Merck leading the way.
A trend is graded on whether the publisher keeps it, never as a hit or a miss (D6, D33).